SEC Filing Summary: BofI Holding, Inc. (Form 8-K)
Business Context and Reporting Period
This Current Report on Form 8-K was filed by BofI Holding, Inc. on July 22, 2014. The filing details the entry into a new Equity Distribution Agreement and the termination of a prior agreement to facilitate the sale of common stock.
Key Financial Metrics and Capital Structure
The filing does not provide specific revenue, profit, cash flow, or margin data. The primary financial metric disclosed relates to capital raising:
- Offering Size: Up to $50,000,000 in aggregate offering price for common stock.
- Commission: 2.5% of gross proceeds paid to Distribution Agents.
- Expense Reimbursement: Up to $75,000 for agent expenses.
- Minimum Sale Threshold: $5,000,000 per calendar quarter if shares are designated for sale.
Material Changes and Agreements
The Company executed the following material changes on July 22, 2014:
- New Agreement: Entered into an Equity Distribution Agreement with Keefe, Bruyette & Woods, Inc., Raymond James & Associates, Inc., and Sterne, Agee & Leach, Inc. to sell shares via "at-the-market" offerings.
- Termination: Terminated the prior Equity Distribution Agreement dated March 11, 2013, with Raymond James and other agents.
- Offering Status: Announced the completion of a previous $50.0 million ATM offering commenced in March 2013 and the initiation of a second $50.0 million ATM offering.
Outlook, Risks, and Management Commentary
Management indicated the new offering will be conducted through "at-the-market" transactions on the NASDAQ Global Select Market or through market makers. The Company retains the right to suspend or terminate the offering at any time. The filing does not contain specific forward-looking guidance on earnings or operational risks beyond the standard terms of the distribution agreement.
Key Facts for Investor Verification
- Verify the completion status and proceeds of the first $50 million ATM offering concluded in July 2014.
- Monitor the execution of the new $50 million ATM offering to assess dilution impact.
- Review the attached Equity Distribution Agreement (Exhibit 1.1) for specific pricing limitations and termination clauses.
- Confirm the identity of the "Designated Agent" for future sales notices.